Dr. Soliman Abdul Kader Fakeeh (4017)
Tadawul
37.40
-0.02 (-0.05%)
Real-time Data
07:00 AM
Day's Range
37.2437.74
52 wk Range
27.2042.84
Financial Statements - 4017 - Dr. Soliman Abdul Kader Fakeeh
Revenue
3.09B▲ 10.7%
Net Income
248.12M▼ 5.9%Net Margin 8.0%
EBITDA
511.58M▼ 6.2%
Free Cash Flow
-75.50M▲ 14.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 3.09B | 2.79B |
| Cost of Goods | 2.38B | 2.09B |
| Gross Profit | 703.89M | 699.03M |
 Operating Expense | - | - |
| Operating Income | 307.99M | 359.06M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 280.45M | 287.06M |
| Income Tax | 32.33M | 23.39M |
| Net Income | 248.12M | 263.67M |
| EPS Basic | 1.26 | 1.32 |
| EPS Diluted | 1.26 | 1.32 |
| Basic Shares Outstanding | 230M | 217.17M |
| Diluted Shares Outstanding | 230M | 217.17M |
| Ebit | 329.30M | 382.73M |
| Ebitda | 511.58M | 545.61M |
| Net Income Continuous Operations | 280.45M | 287.06M |
| Minority Interests | 42.06M | 23.88M |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
